首页> 外文会议>Diagnostic and Therapeutic Cardiovascular Interventions IV >Suppression of neointimal hyperplasia by photodynamic therapy: in vitroand in vivo results,
【24h】

Suppression of neointimal hyperplasia by photodynamic therapy: in vitroand in vivo results,

机译:通过光动力疗法抑制新内膜增生:体内和体外结果,

获取原文

摘要

Abstract: Proliferation of vascular smooth muscle cells (VSMCs) is the pathophysiogical basis of the restenoses which occur in 30-55% of patients undergone revascularisation. Prophylactic measures including pharmacotherapy, endovascular stenting and anti-gene therapy have so far failed to contain this problem. Photodynamic therapy (PDT) may selectively suppress VSMCs and decrease restenosis rates. We report 2 studies; the first examines the effect of PDT on an in-vitro model of NIH and the second involves using endoluminal ablation of an in-vivo model of experimental NIH of the rabbit's aorta. !8
机译:摘要:血管平滑肌细胞(VSMC)的增殖是再狭窄的病理生理基础,这种再狭窄发生在接受血管重建术的患者中占30-55%。迄今为止,包括药物治疗,血管内支架植入和抗基因治疗在内的预防措施未能解决这一问题。光动力疗法(PDT)可以选择性抑制VSMC,降低再狭窄率。我们报告2个研究;第一个研究了PDT对NIH体外模型的影响,第二个研究了对兔主动脉实验性NIH的体内模型的腔内消融。 !8

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号